tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
9IB
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports

Compare Infant Bacterial Therapeutics AB (9IB) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
9IB
Infant Bacterial Therapeutics AB
€4.48
€62.56M
-10.44
0.88%
―
xxxxxxxxxxxxx
9IB
xxxxxxxxxxxxx
XBRANE
Xbrane Biopharma AB
kr10.37
kr145.06M
121.99
-71.35%
―
xxxxxxxxxxxxx
9IB vs XBRANE
xxxxxxxxxxxxx
ACE
Ascelia Pharma AB
kr3.17
kr367.29M
-4.79
8.22%
―
xxxxxxxxxxxxx
9IB vs ACE
xxxxxxxxxxxxx
GUARD
Guard Therapeutics International AB
kr1.38
kr26.30M
-0.24
-89.36%
―
xxxxxxxxxxxxx
9IB vs GUARD
xxxxxxxxxxxxx
IMMU
Immunicum AB
kr5.77
kr286.58M
-1.89
-10.00%
―
xxxxxxxxxxxxx
9IB vs IMMU
xxxxxxxxxxxxx
CANTA
Cantargia AB
kr3.99
kr992.95M
7.07
213.99%
1 Buy
0 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxx
9IB vs CANTA
xxxxxxxxxxxxx

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:9IB
Infant Bacterial Therapeutics AB
4.59
-0.32
-6.43%
SE:XBRANE
Xbrane Biopharma AB
7.04
-15.84
-69.22%
SE:ACE
Ascelia Pharma AB
2.90
0.39
15.34%
SE:GUARD
Guard Therapeutics International AB
1.30
-10.60
-89.04%
SE:IMMU
Immunicum AB
4.68
-0.39
-7.69%
SE:CANTA
Cantargia AB
3.99
2.69
207.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
Compare More Stocks >